Drug Safety & Medicine Alerts
Alzheimer’s treatment: NICE to reevaluate two drugs
Last year, NICE rejected these drugs, pointing out that they are too expensive to be made available in NHS England and Wales.
Mar 24, 2026
This Site is Intended for Healthcare Professionals Only